baber/WOPTO huggingface dataset:
Patent CY-1115156-T1 (CY)
Title: Μεθοδος για την παραγωγη της τελμισαρτανης
Inventor: HAUEL NORBERT
IPC: C07D235/04
Filed: 2013-10-09
Abstract: Αντικείμενο της παρούσας εφεύρεσης είναι μια νέα μέθοδος για την παραγωγή της τελμισαρτάνης με αντίδραση του 2-n-προπυλο-4-μεθυλ-6-(1΄-μεθυλοβενζιμιδαζολ-2’-υλο-βενζιμιδαζολίου με μια ένωση του γενικού τύπου (IV) στον οποίο το Ζ παριστάνει μια αποχωρούσα ομάδα, όπου λαμβάνεται η ένωση 2-κυανο-4΄-[2´´-n-προπυλο-4΄΄-μεθυλ-6’’-(1"'-μεθυλοβενζιμιδαζολ-2'"-υλο)βενζιμιδαζολ-1’’-υλο-μεθυλο]διφαινύλιο, και εν συνεχεία υδρόλυση της ομάδας του νιτριλίου προς ομάδα οξέος.
Patent CY-1115147-T1 (CY)
Title: Εξουδετερωτικα αντισωματα που εχουν ειδικοτητα για ανθρωπινη il-17
Inventor: ADAMS RALPH
IPC: A61K47/48
Filed: 2014-04-08
Abstract: Η εφεύρεση σχετίζεται με ένα μόριο αντισώματος που έχει ειδικότητα για αντιγονικούς καθοριστές της IL-17, τις θεραπευτικές χρήσεις του μορίου αντισώματος και τις μεθόδους παραγωγής του εν λόγω μορίου αντισώματος.
Patent CY-1115173-T1 (CY)
Title: Μορια προσδεσης ικανα για εξουδετερωση του ιου λυσσας και χρησεις αυτων
Inventor: BAKKER ALEXANDER BERTHOLD HENDRIK
IPC: C12N15/63
Filed: 2014-05-21
Abstract: Η παρούσα εφεύρεση παρέχει μόρια πρόσδεσης που προσδένουν ειδικά ιό λύσσας και είναι ικανά να εξουδετερώσουν τον ιό. Η εφεύρεση ακόμη παρέχει μόρια νουκλεϊνικού οξέος που κωδικεύουν τα μόρια πρόσδεσης, συνθέσεις οι οποίες περιλαμβάνουν τα μόρια πρόσδεσης και μεθόδους ταυτοποίησης ή παραγωγής των μορίων πρόσδεσης. Τα μόρια πρόσδεσης μπορούν να χρησιμοποιηθούν στην διάγνωση, προφύλαξη και/ή θεραπεία μιας κατάστασης που προκύπτει από ιό λύσσας. Κατά προτίμηση, αυτά μπορούν να χρησιμοποιηθούν στην μετά την έκθεση προφύλαξη από λύσσα.
Patent CY-1115351-T1 (CY)
Title: Πυριμιδινονες ως αναστολεις ρi3κ
Inventor: LI YUN-LONG
IPC: A61K31/52
Filed: 2014-07-15
Abstract: Η παρούσα εφεύρεση παρέχει πυριμιδινόνες που ρυθμίζουν την δραστικότητα φωσφοϊνοσιτιδίου 3-κινασών (ΡΙ3Κ) και είναι χρήσιμες στην θεραπεία ασθενειών που σχετίζονται με την δραστικότητα των ΡΙ3Κ, που συμπεριλαμβάνουν, για παράδειγμα, φλεγμονώδεις διαταραχές, ανοσο-βασιζόμενες διαταραχές, καρκίνο και άλλες ασθένειες.
Patent CY-1117273-T1 (CY)
Title: Υγρη φαρμακευτικη συνθεση η οποια περιεχει νιτισινονη
Inventor: SVENSSON LENNART
IPC: A61P3/00
Filed: 2016-03-03
Abstract: Η εφεύρεση αναφέρεται σε υγρή φαρμακευτική τυποποίηση κατάλληλη για στοματική χορήγηση, η οποία περιέχει εναιώρημα αποτελεσματικής ποσότητας μικροκατανεμημένης 2-(2-νιτρο-4-τριφθορο-μεθυλβενζοϋλ)-1,3-κυκλοεξανοδιόνης (νιτισινόνης) και ρυθμιστικό κιτρικού οξέος το οποίο έχει pΗ εντός της διακύμανσης 2,5 έως 3,5. Η τυποποίηση είναι χρήσιμη στη θεραπεία διαταραχών και παθήσεων στις οποίες είναι επιθυμητή η αναστολή της 4-υδροξυφαινυλοπυρουβικής διοξυγονάσης (HPPD), π.χ. σε κληρονομική τυροσιναιμία τύπου I.
Patent CY-1117366-T1 (CY)
Title: Χειρουργικο εργαλειο για επεμβασεις στη σπονδυλικη στηλη
Inventor: TENUCCI MIRIA
IPC: A61B17/02
Filed: 2016-04-12
Abstract: Ένα χειρουργικό εργαλείο (1) για επεμβάσεις στη σπονδυλική στήλη, το οποίο περιλαμβάνει ένα σώμα λαβής (2) που περατούται, στο ένα άκρο, με ένα ουσιαστικά επίπεδο τμήμα (5) το οποίο ενσωματώνεται με το σώμα του εργαλείου (1), όπου το ουσιαστικά επίπεδο τμήμα (5) έχει προσαρμοσθεί ώστε να ωθεί επί μίας γάζας (7) για την επιπωμάτιση μίας πληγής.
Patent CY-1119458-T1 (CY)
Title: Διαμορφωσιμος προσαρμοστικος καθολικος ελεγχος και διαχειριση κυκλοφοριας
Inventor: STOLORZ PAUL E
IPC: H04L29/12
Filed: 2017-09-07
Abstract: Πλαίσιο για την παράδοση Διαδικτυακού περιεχομένου περιλαμβάνει δίκτυο εξυπηρετητών συνδρομητή· και τουλάχιστον έναν εξυπηρετητή ονόματος τομέα που δομείται και προσαρμόζεται να παρέχει υπηρεσία ονόματος τομέα βάσει πολιτικών, όπου, σε απόκριση σε κάποια αίτηση για τη μετατροπή κάποιου ονόματος κεντρικού υπολογιστή, ο εξυπηρετητής ονόματος τομέα μετατρέπει το όνομα κεντρικού υπολογιστή σε τουλάχιστον μία διεύθυνση που αντιστοιχεί σε κάποιον εξυπηρετητή στο δίκτυο εξυπηρετητών συνδρομητή βάσει τουλάχιστον ενός ζητήματος πολιτικής. Μερικά παραδείγματα για πιθανές πολιτικές είναι γεωγραφικές πολιτικές, πολιτικές μεριδίου φορτίου ή πολιτικές υπερχείλισης.
Patent CY-1120577-T1 (CY)
Title: Χρησεις διαλυτων μοριων ctla4 μεταλλακτικης παραλλαγης
Inventor: COHEN ROBERT
IPC: A61P37/04
Filed: 2018-05-23
Abstract: Η παρούσα εφεύρεση αφορά σε συνθέσεις και μεθόδους για θεραπεία ρευματικής ασθένειας μέσω χορήγησης σε ένα υποκείμενο, διαλυτών CTLA4 μεταλλακτικών μορίων που αποτρέπουν ενδογενή Β7 μόρια από το να συνδέουν τους εκλεκτικούς προσδέτες αυτών.
Patent CY-1121327-T1 (CY)
Title: Τροποποιημενα αντισωματα anti-il-23p19
Inventor: PRESTA LEONARD G
IPC: A61K39/395
Filed: 2019-01-21
Abstract: Προβλέπονται τροποποιημένα αντισώματα έναντι της ανθρώπινης IL-23pl9 καθώς και χρήσεις αυτών, π.χ. στην αντιμετώπιση φλεγμονωδών, αυτοάνοσων και υπερπλαστικών διαταραχών.
Patent HR-P20110278-T1 (HR)
Inventor: CID-NUNEZ JOSU MARIA
IPC: A61P25/00
Filed: 2011-04-15
Abstract: Spoj koji ima formulu (1) ili njegov stereokemijski izomerni oblik, naznačen time, da R1 je C1-6alkil; ili C1-3alkil supstituiran sa C3-7cikloalkil, fenil, ili fenil supstituiran s halo, trifluorometil ili trifluorometoksi; R2 je halo, trifluorometil, C1-3alkil ili ciklopropil; R3 je vodik, fluoro, hidroksil, hidroksiC1-3alkil, hidroksiC1-3alkiloksi, fluoroC1-3alkil, fluoroC1-3alkiloksi ili cijano; i Ar je nesupstituirani fenil; ili fenil supstituiran s n radikalima R4, pri čemu n je 1, 2 ili 3; R4je odabran iz skupine koja sadrži vodik, halo, C1-3alkil, hidroksiC1-3alkil, polihaloC1-3alkil, cijano, hidroksil, amino, karboksil, C1-3alkiloksiC1-3alkil, C1-3alkiloksi, polihaloC1-3alkiloksi,
Patent HR-P20120107-T1 (HR)
Title: Device for parcelling out cardboard sections
Inventor: GRUMBACH UDO
IPC: B07B13/00
Filed: 2012-02-01
Abstract: The device has a sorting unit comprising a feed area for feeding a bulk of waste paper to a pick-up device (3) with spikes (2). The spikes and the feed area are formed such that the spikes impale cardboard sections of the bulk of waste paper fed from the feed area. The spikes are connected with the pick-up device so that the spikes avoid a preset force during an action. Projections are formed such that the spikes are protected by the projections during contact with a hard object. The feed area has a base (5) with base elements (5b) arranged parallel and transverse to a feed direction.
Patent HR-P20120305-T1 (HR)
Title: Articulated spud carriage
Inventor: VLIES ANTONIE WILLEM VAN DER
IPC: E02F9/06
Filed: 2012-04-10
Abstract: The invention relates to a spud-pile carriage (1) for connecting a spud-pile (8) to a dredging vessel in a wheeled or sliding manner, in which the spud-pile carriage comprises a first (2) and second (3) carriage part, both of which are provided with wheels or sliders, characterized in that the first and second carriage parts are connected so as to be pivotable with respect to one another about a pivot pin.
Patent HR-P20120530-T1 (HR)
Title: Patch
Inventor: STEFFEN BARTH
IPC: A61F13/02
Filed: 2012-06-26
Abstract: An adhesive patch for attaching to the skin for medical, cosmetic, and/or orthopedic purposes. The patch is formed with a film that includes a carrier material, which is provided with a therapeutically effective coating on both sides.
Patent SI-1581434-T1 (SI)
Title: Container
Inventor: MURJAHN KLAUS
IPC: B65D1/00
Filed: 2003-11-08
Abstract: The paint container (10) has a lid (18) with a rim (20) which seals it. The handle (14) swivels upwards and carries pins (26) on its sides which push the lid upwards to open the container.
Patent SI-1526867-T1 (SI)
Title: Erythropoietin in subpolycythemic doses
Inventor: BAHLMANN FERDINAND HERMANN
IPC: A61K38/00
Filed: 2003-07-25
Abstract: Use of erythropoetin (EPO) and/or its derivatives for stimulating, in endothelial precursor cells (EPC), any of physiological mobilization; proliferation; differentiation to endothelial cells and/or migration, in the direction of an angiogenic or vasculogenic stimulus. Independent claims are also included for the following: (1) use of EPO and/or its derivatives for stimulating formation of endothelial cells (EC) and/or for vasculogenesis; (2) use of EPO to produce a transplantable EC product; (3) use of EPO for treating a tissue or organ transplant; (4) use of EPO for pretreatment of tissue or organ transplants; (5) use of EPO to prepare implantable or transplantable, cell-containing in vitro organ or tissue systems; (6) use of EPO for coating vascular prostheses or heart valves; and (7) pharmaceutical composition containing (a) EPO, its derivatives, analogs, modifications or muteins and (b) at least one of vascular endothelial growth factor, PIGF (not defined), granulocyte-macrophage colony-stimulating factor and/or a hydroxymethyl glutarate-CoA reductase inhibitor. ACTIVITY : Antilipemic; Antidiabetic; Antiinflammatory; Antiarteriosclerosis; Cardiant; Vasotropic; Antianginal; Gynecological; Hypotensive; Nephrotropic. No details of tests for any of these activities are given. MECHANISM OF ACTION : Treatment with EPO increases adhesion of EPC and stimulates formation of endothelial tissue and blood vessels.
Patent SI-1861080-T1 (SI)
Title: Idebenone for the treatment of muscular dystrophies
Inventor: MEIER THOMAS
IPC: A61P9/00
Filed: 2006-03-20
Abstract: Use of idebenone for the preparation of a medicament for the treating of a muscular dystrophy in particular for treating and/or preventing weakness and/or loss of skeletal muscle tissue and/or cardiomyopathy associated with a muscular dystrophy.
Patent DE-3587969-T2 (DE)
Inventor: ESSEX MYRON
IPC: G01N33/569
Filed: 1985-11-08
Granted: 1995-05-11
Abstract: A first glycoprotein having a molecular weight of approximately 120,000 daltons in the H9/HTLV-III cell line, of which approximately 90,000 daltons is the unglycosylated moiety, is obtained from cells infected with human T-cell leukemia virus, type III. A second glycoprotein having a molecular weight of approximately 160,000 daltons is also obtained from such cells, of which approximately 90,000 daltons is the unglycosylated moiety and is substantially identical to the unglycosylated moiety of the first glycoprotein. The presence, in a biological specimen, of either of these unglycosylated or of the unglycosylated moiety is indicative of the presence of cells infected by human T-cell leukemia virus. An assay for the glycoprotein or its unglycosylated moiety is a useful diagnostic procedure for determining such infection in biological specimens.
Patent DE-3650748-T2 (DE)
Inventor: VAN DER LELY CORNELIS
IPC: A01K13/00
Filed: 1986-01-15
Granted: 2001-05-10
Abstract: A device for automatically milking animals, such as cows, comprises a computer controlled milking machine with a milking unit (29) having a support (17) for teat cups (52). The support (17) comprises at least two supporting arms carrying the teat cups (52). These supporting arms are provided with hinging means (53, 55, 56) by means of which the teat cups (52) are movable with respect to the further part of the support (17).
Patent DE-3784750-T2 (DE)
Inventor: COCKBURN JOHN BALFOUR
IPC: G07C9/00
Filed: 1987-03-25
Granted: 1993-10-21
Abstract: A security system including a security lock (1) which can be programmed by the use of a master key (3) to recognise specified slave keys (4). The system may include means for digitising a characteristic such as the thumb print, voice pattern, or retinal image of the holder of a slave key so that it is operable only by the key holder himself. The system is applicable inter alia to the protection of motor cars, the control of access to buildings and enclosures, and the restriction of operation of apparatus to authorised personnel.
Patent DE-3786874-T2 (DE)
Inventor: STEIN AMNON
IPC: G06K15/22
Filed: 1987-10-06
Granted: 1993-11-11
Abstract: An internal drum plotter including a laser source (10) producing a laser beam output, apparatus (14) for modulating the laser beam output to apply information content thereto, apparatus (22) for supporting laser recording material in a generally circular cylindrical configuration about a cylinder axis (20) and scanning apparatus (23) for receiving the modulated laser beam and reflecting it onto the laser recording material, the scanning apparatus (23) including a stabilized reflector (26) arranged for rotation about the cylinder axis (20) for reflecting the modulated laser beam directly onto the laser recording material, wherein the stabilized reflector (26) is insensitive to wobble in the position thereof in directions perpendicular to the cylinder axis (20).
Patent DE-3856253-T2 (DE)
Inventor: MATSUMOTO MUNEYUKI
IPC: G03F1/62
Filed: 1988-10-24
Granted: 1999-04-08
Abstract: A dust-proof film is made from a material which contains a cellulose ester and whose transmittances of light having a wavelength of 365 nm and a wavelength of 436 are9g8% or more, or the dust-proof film is formed of cellulose propionate whose weight average molecular weight using polystyrene as a reference is 60,000 - 400,000. The dust-proof film has a long life and excels in light resisting properties with respect to the i-line. In addition, the dust-proof film is useful as a long-life pellicle for a broad line and exhibits high light transmittance properties with respect to both the i-line and the g-line.
Patent DE-3878473-T2 (DE)
Inventor: RUDKIN MARK JONATHAN
IPC: G01N9/00
Filed: 1988-03-07
Granted: 1993-06-17
Abstract: A transducer for measuring a parameter of a fluid, such as density or viscosity, comprises two generally parallel tines extending from a common yoke, forming a tuning fork adapted to be immersed in the fluid. The tines are excited to vibrate resonantly and in anti-phase by one or more piezo-electric exciting elements, which are housed in one or more cavities within the tines or the yoke. The vibrations are sensed by one or more similarly-housed piezo-electric sensing elements. The tines are shaped to enhance their sensitivity to the parameter to be measured: for example they are provided with re-entrant surfaces to enhance density sensitivity, or elongated in the direction in which they vibrate to enhance viscosity sensitivity.
Patent TR-199901161-T2 (TR)
Title: Atese dayanikli sandviç tip paneller
Inventor: CHRISTIANSEN CARSTEN
IPC: B41M5/035
Filed: 1996-12-03
Abstract: Atese dayanikli sandviç panel üretimi için kullanilan bir layner bobini,bir tarafi içerisine poliamid küreciklerin dahil edilmis oldugu polyester tabaka ile kapli olan sürekli bir çelik plakasi aginin (11) süblime edilebilir boya içerisinde sekiller ile baskilanmis sürekli bir çikartma malzemesi agi (12) ile beraber, çelik plaka aginin bir süblimasyon islemi ile baskilanmasi için yüzey temasina getirilmesi ve bunlarin bir isitilmis merdana (13) çevresinin bir kismindan geçirilmesi ile üretilir. Layner hos bir görünüme sahiptir ve bulusa göre üretilen panel yangina dayaniklilik testlerinde üstün bir performans gösterir.
Patent TR-199901212-T2 (TR)
Inventor: WOLFLA A THOMAS
IPC: F16J15/44
Filed: 1997-12-05
Abstract: An abradable seal is provided utilizing a laser to cut a pattern into the surface effective to improve abradability in the area of the pattern.
Patent TR-199903158-T2 (TR)
Inventor: KLAUS BIERBACH
IPC: D06F37/30
Filed: 1998-06-08
Abstract: Çamasir makinesi için çalistirma tertibati olup,  yikama kazaninin arka yüzüne monte edilmistir ve stator sargisini tasiyan bir parça, indüktör sargilari ve bir rotor ile miknatislanabilir kutuplara sahip yassi bir motordan olusur ve yikama kazanini dogrudan hareket ettirir; özelligi, motorun (7,30) stator sargisi tasiyici parçasinin (8,28,38) ve rotorunun (10,43), yikama kazaninin duvarina (3) yapilacak son montajina kadar tasima sirasinda, stator sargisi tasiyici parçanin (8,28,38) ve rotorun (10,43), birbirlerine göre konumlari isletme durumuna uygun bir sekilde, sökülebilir vaziyette baglanmis olmalaridir.
Patent DE-60004763-T2 (DE)
Inventor: SUZUKI TOSHIO
IPC: C12P7/18
Filed: 2000-11-29
Granted: 2004-06-17
Abstract: An industrial and economical method for obtaining a (S)-3-halogeno-1,2-propanediol, which comprises cultivating a microorganism belonging to the genus Pseudomonas which has an ability to assimilate (R)-3-halogeno-1,2-propanediol and can grow by assimilating (R)-3-halogeno-1,2-propanediol as a single carbon source, in a culture medium containing a racemic 3-halogeno-1,2-propanediol as a substrate, and isolating the (S)-3-halogeno-1,2-propanediol from the culture medium.
Patent DE-60006000-T2 (DE)
Inventor: GUINEZ CHARLES
IPC: A61K38/22
Filed: 2000-12-27
Granted: 2004-07-29
Abstract: A method for oral administration of an active principle includes the steps of incorporating an active principle in multilamellar vesicles having a diameter of between 0.1 and 25 mum, and a lamellar liquid-crystal internal structure formed, from the center to the periphery of the vesicles, of a stack of concentric bilayers based on amphiphilic agents alternating with layers of water, aqueous solution or solution of a polar liquid, and orally administering a composition containing the active principle incorporated within the vesicles.
Patent DE-60018279-T2 (DE)
Inventor: SOREQ HERMONA
IPC: C07K16/40
Filed: 2000-05-31
Granted: 2006-02-16
Abstract: The invention relates to antibodies recognizing acetylcholinesterase or a C-terminal peptide derived from acetyl-cholinesterase, useful in diagnosing central nervous system (CNS) stress, elevated glucocorticoid level, disruption of the blood-brain barrier or Alzheimer's disease. The invention also relates to methods for the diagnosis of central nervous system (CNS) stress, elevated glucocorticoid level or disruption of the blood-brain barrier in a mammal, by use of the antibodies of the invention.
Patent DE-60018912-T2 (DE)
Inventor: CHO T
IPC: A61M5/142
Filed: 2000-04-04
Granted: 2006-03-30
Abstract: A monolithic flow controller for controlling the rate at which a medicinal liquid is administered to a patient. The monolithic flow controller includes one or more virtual valves that, because of their relatively small opening size (less than 0.5 mum in diameter), only permit fluid to flow through the valve when a forward bias voltage is applied. If a reverse bias voltage or no voltage is applied, fluid flow through the opening is inhibited. The fluid rate through the device is monitored using two pressure sensors or a differential pressure sensor that determine the differential pressure along the flow path through the device or relative to the external ambient pressure. The flow through the device is equal to the product of the differential pressure and the conductance of the channel in the flow controller. A capacitive bubble sensor is optionally provided to detect bubbles in the medicinal liquid being administered to the patient. The flow controller can be made sufficiently small to be injected into a patient's cardiovascular system or other portion of the patient's body through a hypodermic syringe and needle, or it can be implanted in the patient's body at a desired site. The medicinal liquid can be contained within an integral pressurized fluid reservoir, administered by gravity feed, or conveyed by a pump to an inlet port of the flow controller.
Patent DE-60023879-T2 (DE)
Inventor: MORRELL B
IPC: B60L15/20
Filed: 2000-03-14
Granted: 2006-06-14
Abstract: A system and method for controlling a device such that device operates in a smooth manner. The system may switch between control architectures or vary gain coefficients used in a control loop to control the device. As the architecture or gains are switched, the control signal may be smoothed so that the device does not experience an abrupt change in the control signal it receives. In one embodiment, the control signal may be smoothed by adding a decaying offset value to the control signal to create a smoothed control signal that is applied to the device.
Patent DE-60034960-T2 (DE)
Inventor: NIEDERAUER GABRIELE G
IPC: A61L27/46
Filed: 2000-10-30
Granted: 2008-02-14
Abstract: A biodegradable therapeutic implant material having a bimodal degradation profile made from a biodegradable polymer having a biodegradable ceramic substantially uniformly distributed therein is provided. Preferably the material is nonporous (fully dense). Methods of using the materials of this invention for healing of defects in bone, cartilage, and other tissues are also provided. Methods of making such therapeutic implant materials are also provided including the steps of preparing the polymer in uncured form, mixing particles of a biodegradable ceramic into said polymer, and applying heat and pressure to the mixture to produce a substantially nonporous, cohesive implant material. Methods of making porous implants by dissolving out the biodegradable ceramic materials <i>in vivo</i> or <i>in vitro</i> are also provided as are the porous implant themselves.
Patent DE-60035419-T2 (DE)
Inventor: MASIGNANI VEGA
IPC: G01N33/569
Filed: 2000-05-19
Granted: 2008-02-28
Abstract: W099/24578 discloses a large number of proteins from Neisseria meningitidis and Neisseria gonhorroeae The present invention relates to fragments of the protein having the amino acid sequence set forth in SEQ ID NO:650 of W099/24578, which fragments comprise at least one antigenic determinant of said protein.
Patent DE-60038606-T2 (DE)
Inventor: ABU-JAWDEH PAULINE
IPC: C10L1/32
Filed: 2000-03-06
Granted: 2009-07-16
Abstract: There is provided a composition for preparing a water-in-oil emulsion, wherein the average droplet size of the water phase of the water-in-oil emulsion is no greater than 01 mum. In a preferred embodiment of the invention, the oil is a fuel.
Patent DE-60102077-T2 (DE)
Inventor: WATES MARY
IPC: C09K23/00
Filed: 2001-03-01
Granted: 2004-12-02
Abstract: A method of emulsifying asphalt using a polyamine polyoxide, preferably a diamine dioxide, as an emulsifier or co-emulsifier and an emulsion of asphalt, water and a polyamine polyoxide, preferably a diamine dioxide. The advantages of using a polyamine polyoxide as an emulsifier or co-emulsifier include its ability to provide superior cationic and anionic emulsions, and slow-setting emulsions at low use levels, and the excellent adhesion of the cured asphalt film.
Patent DE-60108565-T2 (DE)
Inventor: CASSAI PAOLO
IPC: B61D33/00
Filed: 2001-07-27
Granted: 2006-01-05
Abstract: A method of producing a seat (1a; 1b) for rail vehicles includes the steps of producing a first supporting panel (6) forming part of a backrest (5) of the seat (1a; 1b), and producing a second supporting panel (6) forming part of a seat portion (4) for connection to the respective backrest (5); the panels (6) are produced by forming a common starting element, elongated in a longitudinal direction (A) and having a cross section of constant shape and size in the longitudinal direction (A), and by cutting the starting element transversely into a number of pieces, each defining a respective panel (6). <IMAGE>
Patent DE-60115113-T2 (DE)
Inventor: YAMAGUCHI YASUHIDE
IPC: H01G4/008
Filed: 2001-02-02
Granted: 2006-08-03
Abstract: Nickel powder herein disclosed has an average particle size, as determined by the observation with SEM, of not more than 1  mu m, a particle density of not less than 8.0 g/cm<3>, and an average diameter of crystallites present in the nickel particles of not more than 550 ANGSTROM  . Moreover, a conductive paste for a multilayer ceramic capacitor comprises the foregoing nickel powder. The nickel powder and the conductive paste containing the same can control heat shrinkage while inhibiting any rapid oxidation and permit the production of a thin, uniform internal electrode for a multilayer ceramic capacitor without being accompanied by any crack formation and delamination during firing.
Patent DE-60116116-T2 (DE)
Inventor: PETRASH STANISLAW
IPC: C08J7/046
Filed: 2001-09-13
Granted: 2006-07-13
Abstract: The present invention is directed to the use of a polymer coating composition having a dispersant, microbeads and a high Tg polymer with a Tg of greater than -10° C. for the inner coating on natural and synthetic rubber articles, particularly for latex gloves. The coating for rubber articles, provides an inner surface coating that reduces friction between the latex and the hand to allow convenient donning. They are deliverable from aqueous solution.